EMIS
NASDAQEmmis Acquisition Corp.
Price$10.12+0.11 (+1.10%)
2026-03-022026-06-03
News · 26 weeks7+100%
2025-12-072026-05-31
Mix290d
- SEC Filings2(100%)
Latest news
13 items- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
- SECSEC Form 10-K filed by Emmis Acquisition Corp.10-K - Emmis Acquisition Corp. (0002075816) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Emmis Acquisition Corp.SCHEDULE 13G/A - Emmis Acquisition Corp. (0002075816) (Subject)
- PRSichenzia Ross Ference Carmel LLP Achieves Firm Record Advising on Over 170 Transactions Totaling Over $14 Billion in 2025NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Sichenzia Ross Ference Carmel LLP ("SRFC") reported that in 2025 it advised on over 170 announced transactions, with the total value of these transactions exceeding $14 billion, far surpassing the firm's strong performance in 2024. The transactions, on behalf of various market participants, such as issuers, underwriters and investors, included initial public offerings, secondary public offerings, registered direct offerings, private placements, mergers, acquisitions and cryptocurrency transactions. In October of 2025, for the fifth consecutive quarter, SRFC was ranked first in the nation for issuer counsel among securities law firms in Placement
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- SECSEC Form SCHEDULE 13G filed by Emmis Acquisition Corp.SCHEDULE 13G - Emmis Acquisition Corp. (0002075816) (Subject)
- INSIDERSEC Form 3 filed by new insider Mallon-De Castro Anna Christin3 - Emmis Acquisition Corp. (0002075816) (Issuer)
- SECSEC Form 10-Q filed by Emmis Acquisition Corp.10-Q - Emmis Acquisition Corp. (0002075816) (Filer)
EMIS FAQ
5 questionsWhere does EMIS stock trade?
Emmis Acquisition Corp. (EMIS) is listed on NASDAQ.What sector and industry is EMIS in?
Emmis Acquisition Corp. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Emmis Acquisition Corp. go public?
Emmis Acquisition Corp. (EMIS) completed its IPO in 2025.What companies are similar to EMIS?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare EMIS side-by-side with any of them on Quantisnow.How can I track EMIS on Quantisnow?
Quantisnow aggregates Emmis Acquisition Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EMIS to receive live email and push alerts on every new disclosure.